Metagenomi, Inc. (MGX)
NASDAQ: MGX · IEX Real-Time Price · USD
6.17
-0.87 (-12.36%)
At close: May 2, 2024, 4:00 PM
6.18
+0.01 (0.16%)
After-hours: May 2, 2024, 7:59 PM EDT
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $231.20 million as of May 2, 2024.
Market Cap
231.20M
Enterprise Value
3.00M
1-Year Change
n/a
Ranking
Category
Stock Price
$6.17
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $231.20M, a decrease of -58.93%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 1, 2024 | 263.80M | 0.27% |
Apr 30, 2024 | 263.10M | -13.31% |
Apr 29, 2024 | 303.50M | 7.55% |
Apr 26, 2024 | 282.20M | 11.72% |
Apr 25, 2024 | 252.60M | -0.12% |
Apr 24, 2024 | 252.90M | -3.99% |
Apr 23, 2024 | 263.40M | 5.23% |
Apr 22, 2024 | 250.30M | -3.06% |
Apr 19, 2024 | 258.20M | -11.09% |
Apr 18, 2024 | 290.40M | -6.05% |
Apr 17, 2024 | 309.10M | -0.26% |
Apr 16, 2024 | 309.90M | -3.16% |
Apr 15, 2024 | 320.00M | -4.71% |
Apr 12, 2024 | 335.80M | -5.06% |
Apr 11, 2024 | 353.70M | 0.43% |
Apr 10, 2024 | 352.20M | -9.81% |
Apr 9, 2024 | 390.50M | 5.91% |
Apr 8, 2024 | 368.70M | 0.08% |
Apr 5, 2024 | 368.40M | -2.57% |
Apr 4, 2024 | 378.10M | -3.82% |
Apr 3, 2024 | 393.10M | 2.24% |
Apr 2, 2024 | 384.50M | -5.18% |
Apr 1, 2024 | 405.50M | 2.58% |
Mar 28, 2024 | 395.30M | -4.88% |
Mar 27, 2024 | 415.60M | -2.17% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vanda Pharmaceuticals | 272.07M |
Adaptimmune Therapeutics | 266.73M |
Agenus | 265.63M |
EDAP TMS | 264.56M |
Werewolf Therapeutics | 264.12M |
ChromaDex | 263.58M |
Akebia Therapeutics | 262.76M |
Xeris Biopharma Holdings | 262.41M |